Trial Profile
A Randomized, Open-Label, Four-Cohort, Parallel Design Study to Evaluate the Effect of Itraconazole or Rifampin on the Single-Dose Pharmacokinetics of BMS-986205 in Normal Healthy Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Linrodostat (Primary) ; Itraconazole; Rifampicin
- Indications Cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 26 Feb 2018 Status changed from not yet recruiting to completed.
- 21 Nov 2017 New trial record